KOREA UNITED PHARM. INC. revenue breakdown overview

KOREA UNITED PHARM. INC. revenue for the last year amounted to 288.70 B KRW, the most of which — 288.71 B KRW — came from its highest performing source at the moment, Pharmaceutical, the year earlier bringing 278.94 B KRW. The greatest contribution to the revenue figure was made by South Korea — last year it brought KOREA UNITED PHARM. INC. 259.83 B KRW, and the year before that — 255.19 B KRW.